DRESS syndrome: A literature review and treatment algorithm

Drug reaction with eosinophilia and systemic symptoms, known by its acronym in English as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), clinically manifests with fever, facial edema, lymphadenopathy, a morbilliform rash, and organ involvement. Laboratory results reveal leukocytosis,...

Full description

Bibliographic Details
Main Authors: Ana María Calle, MD, Natalia Aguirre, MD, Juan Camilo Ardila, MD, Ricardo Cardona Villa, MD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455122000497
_version_ 1827970714433486848
author Ana María Calle, MD
Natalia Aguirre, MD
Juan Camilo Ardila, MD
Ricardo Cardona Villa, MD
author_facet Ana María Calle, MD
Natalia Aguirre, MD
Juan Camilo Ardila, MD
Ricardo Cardona Villa, MD
author_sort Ana María Calle, MD
collection DOAJ
description Drug reaction with eosinophilia and systemic symptoms, known by its acronym in English as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), clinically manifests with fever, facial edema, lymphadenopathy, a morbilliform rash, and organ involvement. Laboratory results reveal leukocytosis, atypical lymphocytes, eosinophilia, and alterations of liver and kidney function tests. The actual incidence of DRESS is unknown, because it may vary depending on the type of medication and the immune status of each patient; also, because many cases remain undiagnosed or untreated. The drugs most associated with DRESS include antiepileptics, antibiotics, antituberculosis, and non-steroidal anti-inflammatory agents (NSAIDs). Its diagnosis is sometimes made late and can become a challenge. The diagnostic criteria proposed by the international Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) help to establish the diagnosis through a score system based on clinical and laboratory findings. The first step to identify the culprit is a thorough clinical history that includes all suspects, emphasizing those most known to cause DRESS syndrome according to the context and the literature. A skin biopsy may also be helpful in the diagnostic process. Patch testing is the test of choice to search for the culprit in cases of DRESS. Regarding prognosis, the estimated mortality due to DRESS is 3.8%. The main causes of mortality include fulminant hepatitis and liver necrosis. Several indicators of poor prognosis have been identified and these include an eosinophil count above 6000 × 103/μL, thrombocytopenia, pancytopenia, leukocytosis and coagulopathy. This article aims to review the evidence available regarding the epidemiology, pathophysiology, clinical and laboratory findings, diagnosis, and treatment of DRESS.
first_indexed 2024-04-09T18:57:50Z
format Article
id doaj.art-1a23caf49fca4520a600958ec0e8df7e
institution Directory Open Access Journal
issn 1939-4551
language English
last_indexed 2024-04-09T18:57:50Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series World Allergy Organization Journal
spelling doaj.art-1a23caf49fca4520a600958ec0e8df7e2023-04-09T05:46:08ZengElsevierWorld Allergy Organization Journal1939-45512023-03-01163100673DRESS syndrome: A literature review and treatment algorithmAna María Calle, MD0Natalia Aguirre, MD1Juan Camilo Ardila, MD2Ricardo Cardona Villa, MD3Grupo de Alergología Clínica y Experimental (GACE), Universidad de Antioquia, Medellín, Colombia; Clinical Allergologist, Universidad de Antioquia, Medellín, ColombiaGrupo de Alergología Clínica y Experimental (GACE), Universidad de Antioquia, Medellín, Colombia; Clinical Allergologist Resident, Universidad de Antioquia, Medellín, Colombia; Corresponding author. Clinical Allergology Resident, Universidad de Antioquia, Medellín, Colombia.Grupo de Alergología Clínica y Experimental (GACE), Universidad de Antioquia, Medellín, Colombia; Clinical Allergologist Resident, Universidad de Antioquia, Medellín, ColombiaGrupo de Alergología Clínica y Experimental (GACE), Universidad de Antioquia, Medellín, Colombia; Clinical Allergologist, Universidad de Antioquia, Medellín, ColombiaDrug reaction with eosinophilia and systemic symptoms, known by its acronym in English as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms), clinically manifests with fever, facial edema, lymphadenopathy, a morbilliform rash, and organ involvement. Laboratory results reveal leukocytosis, atypical lymphocytes, eosinophilia, and alterations of liver and kidney function tests. The actual incidence of DRESS is unknown, because it may vary depending on the type of medication and the immune status of each patient; also, because many cases remain undiagnosed or untreated. The drugs most associated with DRESS include antiepileptics, antibiotics, antituberculosis, and non-steroidal anti-inflammatory agents (NSAIDs). Its diagnosis is sometimes made late and can become a challenge. The diagnostic criteria proposed by the international Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) help to establish the diagnosis through a score system based on clinical and laboratory findings. The first step to identify the culprit is a thorough clinical history that includes all suspects, emphasizing those most known to cause DRESS syndrome according to the context and the literature. A skin biopsy may also be helpful in the diagnostic process. Patch testing is the test of choice to search for the culprit in cases of DRESS. Regarding prognosis, the estimated mortality due to DRESS is 3.8%. The main causes of mortality include fulminant hepatitis and liver necrosis. Several indicators of poor prognosis have been identified and these include an eosinophil count above 6000 × 103/μL, thrombocytopenia, pancytopenia, leukocytosis and coagulopathy. This article aims to review the evidence available regarding the epidemiology, pathophysiology, clinical and laboratory findings, diagnosis, and treatment of DRESS.http://www.sciencedirect.com/science/article/pii/S1939455122000497Drug hypersensitivityDrug reactionDRESSDIHSEosinophilia
spellingShingle Ana María Calle, MD
Natalia Aguirre, MD
Juan Camilo Ardila, MD
Ricardo Cardona Villa, MD
DRESS syndrome: A literature review and treatment algorithm
World Allergy Organization Journal
Drug hypersensitivity
Drug reaction
DRESS
DIHS
Eosinophilia
title DRESS syndrome: A literature review and treatment algorithm
title_full DRESS syndrome: A literature review and treatment algorithm
title_fullStr DRESS syndrome: A literature review and treatment algorithm
title_full_unstemmed DRESS syndrome: A literature review and treatment algorithm
title_short DRESS syndrome: A literature review and treatment algorithm
title_sort dress syndrome a literature review and treatment algorithm
topic Drug hypersensitivity
Drug reaction
DRESS
DIHS
Eosinophilia
url http://www.sciencedirect.com/science/article/pii/S1939455122000497
work_keys_str_mv AT anamariacallemd dresssyndromealiteraturereviewandtreatmentalgorithm
AT nataliaaguirremd dresssyndromealiteraturereviewandtreatmentalgorithm
AT juancamiloardilamd dresssyndromealiteraturereviewandtreatmentalgorithm
AT ricardocardonavillamd dresssyndromealiteraturereviewandtreatmentalgorithm